Rankings
▼
Calendar
BMRN
BioMarin Pharmaceutical Inc.
Mkt Cap
$12B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$3.2B
Net Income (TTM)
$349M
EPS (TTM)
$1.80
Free Cash Flow (TTM)
$725M
Gross Margin
77.1%
Op. Margin
16.6%
Net Margin
10.8%
FCF Margin
22.5%
P/S Ratio (TTM)
3.7x
P/E Ratio (TTM)
34.1x
YoY Rev Growth
+12.9%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$596M
$461M
$62M
Q2 23
$595M
$465M
$66M
Q3 23
$581M
$453M
$31M
Q4 23
$646M
$511M
$14M
Q1 24
$649M
$524M
$88M
Q2 24
$712M
$582M
$120M
Q3 24
$746M
$557M
$114M
Q4 24
$747M
$611M
$161M
Q1 25
$745M
$594M
$224M
Q2 25
$825M
$675M
$277M
Q3 25
$776M
$636M
-$47M
Q4 25
$875M
$579M
$79M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
5.5x
166.2x
Q2 23
5.3x
119.1x
Q3 23
5.2x
81.0x
Q4 23
4.9x
71.0x
Q1 24
4.8x
57.9x
Q2 24
4.6x
46.4x
Q3 24
4.3x
36.9x
Q4 24
4.2x
27.9x
Q1 25
4.0x
22.7x
Q2 25
3.9x
18.1x
Q3 25
3.8x
22.9x
Q4 25
3.7x
34.1x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$74M
-$99M
Q2 23
$70M
$47M
Q3 23
$136M
$112M
Q4 23
$27M
-$9M
Q1 24
$47M
$13M
Q2 24
$119M
$97M
Q3 24
$221M
$200M
Q4 24
$186M
$165M
Q1 25
$174M
$158M
Q2 25
$185M
$168M
Q3 25
$369M
$340M
Q4 25
$100M
$59M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$25M
Q2 23
$23M
Q3 23
$23M
Q4 23
$37M
Q1 24
$34M
Q2 24
$22M
Q3 24
$21M
Q4 24
$20M
Q1 25
$17M
Q2 25
$17M
Q3 25
$28M
Q4 25
$41M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+14.8%
+39.8%
Q2 23
+11.5%
+7.1%
Q3 23
+15.0%
+8.5%
Q4 23
+20.2%
+12.4%
Q1 24
+8.8%
+4.9%
Q2 24
+19.6%
+11.7%
Q3 24
+28.3%
+14.7%
Q4 24
+15.6%
-7.3%
Q1 25
+14.8%
-7.0%
Q2 25
+15.9%
-7.3%
Q3 25
+4.1%
+30.2%
Q4 25
+17.0%
+35.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$54M
9.0%
Q2 23
$50M
8.4%
Q3 23
$48M
8.3%
Q4 23
$55M
8.5%
Q1 24
$58M
9.0%
Q2 24
$48M
6.7%
Q3 24
$43M
5.8%
Q4 24
$52M
6.9%
Q1 25
$38M
5.1%
Q2 25
$48M
5.8%
Q3 25
$49M
6.3%
Q4 25
$47M
5.4%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$172M
$105M
$106M
Q2 23
$177M
$91M
$116M
Q3 23
$191M
$51M
$122M
Q4 23
$206M
$142M
$133M
Q1 24
$205M
$107M
$119M
Q2 24
$184M
$140M
$123M
Q3 24
$185M
$145M
$109M
Q4 24
$174M
$141M
$126M
Q1 25
$159M
$104M
$103M
Q2 25
$161M
$110M
$122M
Q3 25
$409M
$137M
$131M
Q4 25
$192M
$802M
—
marketcaparena.com
Revenue Segments
Product
Royalty And Other
Quarter
Product
Royalty And Other
Q1 24
$638M
$11M
Q2 24
$702M
$10M
Q3 24
$734M
$12M
Q4 24
$736M
$12M
Q1 25
$735M
$11M
Q2 25
$813M
$12M
Q3 25
$761M
$15M
Q4 25
$859M
$15M
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$580M
$572M
$1.2B
Q2 23
$694M
$477M
$1.2B
Q3 23
$785M
$340M
$1.1B
Q4 23
$755M
$319M
$1.1B
Q1 24
$747M
$300M
$1.0B
Q2 24
$972M
$252M
$1.2B
Q3 24
$675M
$255M
$930M
Q4 24
$943M
$195M
$1.1B
Q1 25
$1.0B
$224M
$1.3B
Q2 25
$1.2B
$218M
$1.4B
Q3 25
$1.3B
$228M
$1.5B
Q4 25
$1.3B
$249M
$1.6B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
194M
+4.5%
Q2 23
195M
+0.3%
Q3 23
191M
-2.0%
Q4 23
192M
+0.3%
Q1 24
199M
+3.9%
Q2 24
201M
+0.6%
Q3 24
197M
-1.7%
Q4 24
197M
-0.3%
Q1 25
196M
-0.1%
Q2 25
197M
+0.1%
Q3 25
192M
-2.3%
Q4 25
197M
+2.8%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$446K
2K
FY 15
$412K
2K
FY 16
$487K
2K
FY 17
$509K
3K
FY 18
$523K
3K
FY 19
$568K
3K
FY 20
$608K
3K
FY 21
$606K
3K
FY 22
$680K
3K
FY 23
$711K
3K
FY 24
$939K
3K
FY 25
$16K
200K
marketcaparena.com
BMRN (BioMarin Pharmaceutical Inc.) Stock Financials & Earnings | Market Cap Arena